Botulinum Toxin Market, [by Product Type (Botulinum Toxin Type A (Dysport, Xeomin, Botox, Others), Botulinum Toxin Type B); by Application (Therapeutic Use, Cosmetic Use)]; and Geography - Trend, Analysis and Forecast till 2025

Report Summary

The全球肉毒毒素市场规模to observe an effective growth due to factors such as its rising application in various cosmetic surgeries and various therapeutic application.

Botulinum toxin (BTX), is produced from the bacteria known as clostridium botulinum and its relative species. BTX is a neurotoxic protein, that prevents the release of the neurotransmitter acetylcholine which causes flaccid paralysis. Botulinum toxin is majorly used for cosmetic application which enhances the facial appearance and reducing the signs of aging. This reduces the frown lines, and crow’s feet line.

肉毒毒素也用于治疗各种医学问题，如肌肉痉挛，偏头痛，和过度活跃的神经紊乱，导致过度出汗，一些过敏症状，和一些慢性疼痛。尽管肉毒杆菌毒素的应用和疗效多种多样，但它具有心律失常、心脏病发作、心脏骤停等慢性副作用。因此，考虑到这一副作用，美国食品和药物管理局在2008年规定了用于各种化妆品目的的肉毒杆菌毒素的使用指南。

Rising botulinum toxin use in therapeutic application for treating severe axillary applications to boost the botulinum toxin market.

肉毒杆菌毒素的市场份额主要是由以下因素推动的：对整容手术的需求不断增长，以使女性看起来更有吸引力，以及对BTX用于各种治疗应用的认识不断提高。此外，发展中国家对BTX新的治疗应用的研发投入的增加以及对肉毒杆菌素和营养不良使用意识的提高，预计将影响肉毒杆菌毒素市场的增长。同样，在一些主要国家中，Xeomin用于治疗宫颈肌张力障碍和眼睑痉挛的应用日益增多，也将在不久的将来刺激BTX的市场。

Similarly, secondary factors such as rising prevalence of geriatric population globally, increasing incidences of cosmetic surgeries, and growing awareness for this BTX in the developing countries will push the market positively in the coming years.

However, high cost of botulinum toxin and lack of availability of the drug would hinder the growth of botulinum toxin market share during the forecast period. Similarly, the severe side effects caused by the use of botulinum toxin might also hamper the market growth.

Global Botulinum Toxin Market Taxonomy

The botulinum toxin market is segmented on the basis of product, application and geography.

On the basis of product type, the global botulinum toxin market is segmented as:

• A型肉毒毒素
• 呼吸困难
• 至强
• 肉毒杆菌
• 其他
• B型肉毒毒素

根据应用类型，全球肉毒毒素市场细分为：

• Therapeutic Use
• Cosmetic Use

Geographically, the botulinum toxin market size is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Regionally, North America is expected to dominate the global botulinum toxin market size over the forecast period and would continue the same in the future. The growth of North America’s botulinum toxin market is majorly driven by the growing disposable income of the population, increasing health expenditure, and increased number of cosmetic surgeries in this region. Also, rising number demand for botulinum in North America would also spur this market during the forecast period.

Europe is observed to hold the second largest share in the botulinum toxin market due to the increased awareness for cosmetic surgeries supported by large number of cosmetology clinics, and rising number of geriatric population in Europe.

然而，在预测期内，亚太市场预计将出现最快的增长。越来越多的老年人口，以及越来越多的意识到使用肉毒杆菌毒素是主要因素，预计在未来几年管理肉毒杆菌毒素市场。

Key players in the global botulinum toxin market are:

• Allergan Inc.
• Medytox Inc.
• Ipsen Group
• Revance Therapeutics, Inc.
• Lanzhou Institute of Biological Products Co. Ltd.
• Merz GmbH and Co. KGaA
• 美国Worldmed有限责任公司
• Pfizer Inc.
• Gladerma Laboratories